DWA
ETNB

Dorsey Wright & Associates’s 89bio ETNB Stock Holding History

Dorsey Wright & Associates’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,803
Closed -$43.3K – 183
2023
Q3 		$43.3K Sell
2,803
-97
-3% -$1.63K 0.01% 148
2023
Q2 		$55K Buy
2,900
+291
+11% +$5.11K 0.02% 136
2023
Q1 		$39.7K Sell
2,609
-291
-10% -$3.79K 0.01% 139
2022
Q4 		$36.9K Buy
+2,900
New +$26.1K 0.01% 156

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Dorsey Wright & Associates's ETNB Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of 89bio (ETNB) in Q4 2023, closing a stake of 2,803 shares — an estimated $43.3K sold.

Dorsey Wright & Associates first reported a position in ETNB in Q4 2022 and held it in 4 quarters. The position peaked at $55K in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,803 89bio shares in Q4 2023, an estimated $43.3K.
  • Dorsey Wright & Associates first reported a position in 89bio in Q4 2022 and held it in 4 quarters.
  • Dorsey Wright & Associates's 89bio position peaked at $55K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.